包装 | 价格(元) |
10mM (in 1mL DMSO) | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
Kinase experiment: | [3H]LY2119620 equilibrium binding is achieved by incubating 15 μg membranes, orthosteric ligand (100 μM), and various concentrations of [3H]LY2119620 (0.2 to 60 nM) for 1 hour at 25℃. The specific binding versus time data are fit to a one-site specific binding model, and the Bmax and Kd for the allosteric molecule are calculated for each orthosteric ligand[1]. |
产品描述 | LY2119620 is a selective positive allosteric modulator of M2/M4 receptor [1]. Muscarinic acetylcholine receptors (M1-M5) are G-protein coupled receptors regulating the action of the neurotransmitter ACh and play an important role in smooth muscle control, exocrine gland function, mood and cognition [1]. LY2119620 is a selective positive allosteric modulator of M2/M4 receptor. In [35S]GTPγS-binding experiments, LY2119620 exhibited a modest allosteric agonism of 23.2% and 16.8% at the M2 and M4 receptors, respectively. LY2119620 and ACh binding caused cooperativity factor α of 79.4 and 19.5 for the M4 receptor and the M2 receptor, respectively. The cooperativity between LY2119620 and orthosteric agonists (Iperoxo or Oxo-M) was also observed [1]. M2 receptor simultaneously bound to LY2119620 and iperoxo. LY2119620 exhibited mild negative cooperativity with the inverse agonist NMS and strong positive cooperativity with iperoxo [2]. LY2119620 significantly increased Bmax values without changes in Kd when cooperativity binding of [3H]LY2119620 with mAChR, suggesting a G protein-dependent process [3]. References: |